Department of Pediatrics, Keck School of Medicine University of Southern California, Los Angeles, CA, USA.
Diabetes and Obesity Program, Center for Endocrinology, Diabetes, and Metabolism, Department of Pediatrics, Children's Hospital Los Angeles and Keck School of Medicine of USC, Los Angeles, CA, USA.
Child Obes. 2023 Sep;19(6):428-433. doi: 10.1089/chi.2022.0088. Epub 2022 Aug 23.
This survey-based study identified views on antiobesity medications in youth referred to a weight management program. One parent completed a 14-item Research Electronic Data Capture (REDcap) survey regarding openness to medication use in youth with obesity at their first visit in a weight management program. Medical data were extracted from the medical records of all responders. Ninety-four percent (116/125) of parents approached completed the survey (youths' demographic: mean age = 14.1 years old, 46.8% female, 68.8% Hispanic). Results indicate that 75% of parents surveyed were open to medication use. There was no difference in sex, age, insurance, severity of obesity, or family history between parents who were and were not open to medication (all > 0.05). Hispanic ethnicity was associated with greater openness to medication use (odds ratio: 3.4, 95% confidence interval: 1.4-8.5, = 0.007). These results highlight the importance of parental perceptions of medication use for obesity treatment and suggest a need for improved education about the role of medication in the management of pediatric obesity.
本基于调查的研究旨在了解转至体重管理项目的青少年对肥胖症治疗药物的看法。一位家长在参加体重管理项目的首次就诊时,通过 Research Electronic Data Capture(REDCap)完成了一份关于其对肥胖青少年使用药物的开放性的 14 项调查。所有应答者的医疗数据均从其病历中提取。94%(116/125)接受访谈的家长完成了调查(青少年的人口统计学特征:平均年龄为 14.1 岁,46.8%为女性,68.8%为西班牙裔)。结果表明,接受调查的家长中有 75%表示愿意使用药物。在性别、年龄、保险、肥胖严重程度或家庭病史方面,愿意和不愿意使用药物的家长之间没有差异(均 >0.05)。西班牙裔血统与更愿意使用药物相关(优势比:3.4,95%置信区间:1.4-8.5,=0.007)。这些结果突显了家长对肥胖症治疗药物使用的看法的重要性,并表明需要加强对药物在儿科肥胖症管理中作用的教育。